lobbying_activities: 1301649

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1301649	a0a183f0-71f0-4739-b986-01e29836be76	Q3	VAN SCOYOC ASSOCIATES	39837	NATURAL PRODUCTS ASSOCIATION	2012	third_quarter	LAW	S.3431, Designer Anabolic Steroid Control Act, Dietary supplement issues Dehydroepiandrosterone Abuse Reduction Act, Dietary supplement issues Public Law 109-462, Dietary Supplement and Nonprescription Drug Consumer Protection Act, Implementation regarding dietary supplement issues S.605/H.R.1254, Dangerous Synthetic Drug Control Act of 2011, entire bill as it relates to dietary supplements S.409/H.R.1571, Combating Dangerous Synthetic Stimulants Act of 2011, entire bill as it relates to dietary supplements	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2012-10-17T06:48:58.170000-04:00